CPB vs SLE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CPB Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to The Campbell's Company Common Stock (CPB) driven by superior Valuation, Growth & Margin, Options & Structure while SLE counters with relative strength in Momentum & Technical. Fundamentally, CPB trades at 12.3x Forward P/E with 12.4% operating margin (-7.9% YoY revenue) versus SLE at N/M Forward P/E and -121.0% operating margin (+0.3% YoY). In options structure, CPB sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro) against SLE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CPB Revenue | SLE Revenue | CPB Op. Margin | SLE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $8.11B | $0M | 12.1% | -1916.1% | CPB |
| FY2020 | $8.69B | $0M | 12.7% | -908.1% | CPB |
| FY2021 | $8.48B | $10M | 18.2% | -214.9% | CPB |
| FY2022 | $8.56B | $20M | 13.6% | -431.8% | CPB |
| FY2023 | $9.36B | $30M | 14.0% | -130.9% | CPB |
| FY2024 | $9.64B | $20M | 10.4% | -103.5% | CPB |
| FY2025 | $10.2B | $10M | 11.0% | -115.1% | CPB |
| FY2026 | $9.74B | N/A | 8.7% | N/A | CPB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CPB | SLE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.8B | $13.2M | Larger Scale | CPB |
| Trailing P/E Ratio Valuation | 17.4x | 0.1x | Lower Multiple | SLE |
| Forward P/E Ratio Valuation | 12.3x | N/M | Lower Multiple | CPB |
| Revenue Growth (YoY) Growth | -7.9% | +0.3% | Higher Growth | SLE |
| Operating Margin (TTM) Profitability | 12.4% | -121.0% | Higher Margin | CPB |
| Net Profit Margin Profitability | 4.1% | -190.3% | Higher Margin | CPB |
| Return on Equity (ROE) Capital Efficiency | 10.1% | -504.0% | Higher ROE | CPB |
| 52-Week Range Position Momentum | 36% ($19โ$32) | 42% ($0โ$9) | Stronger Trend | SLE |
| Beta / 30D Volatility Risk Regime | -0.34ฮฒ ยท 44% Vol | 0.09ฮฒ ยท 90% Vol | Lower Realized Risk | CPB |
| Unified Institutional Score Composite Signal | 32.0 / 100 (SELL) | 62.1 / 100 (BUY) | Higher Composite | SLE |